Navigation Links
Curecumin May Be an Effective Treatment for Lung Cancer

MAUI, Hawaii, March 27, 2007 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") today announced that its Curecumin(TM) (a Bioresonant Phytotherapeutic(R) form of Turmeric containing curcumin in a liquid nasal delivery system) may be an important treatment for Lung Cancer.

In a recent study published in Science Direct, "Induction of Apoptosis in Human Lung Cancer Cells by Curcumin," conducted at the Department of Medicine, Pediatrics and Family and Preventive Medicine, School of Medicine, University of California, San Diego, scientists concluded, "Curcumin, a phenolic compound from the rhizome of the plant Curcuma longa has anti-inflammatory, antioxidant and anti-cancer activities... This study investigated the cellular and molecular changes induced by curcumin leading to the induction of apoptosis in human lung cancer cell lines -- A549 and H1299... Curcumin inhibited the growth of both the cell lines in a concentration dependent manner... Curcumin induced apoptosis in both the lung cancer cell lines."

Lung cancer is the leading cause of cancer death in the United States, causing 30% of all cancer deaths. It is estimated by the American Cancer Society that "More than 213,380 in the United States will be diagnosed with lung cancer this year and there will be 160,390 deaths from lung cancer in 2007."

"We are particularly interested in the potential of our Curecumin(TM) product to provide a viable treatment strategy for those with lung cancer. Especially, because the liquid form of Curecumin, in a nasal delivery system, will send the formula directly to the lungs. If proven effective, we may have an efficacious, cost effective, natural treatment for lung cancer sufferers." said Steven M. Schorr, Chairman & CEO -- Bioponic Phytoceuticals, Inc.

Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytother
'"/>




Page: 1 2

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
3. Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
4. Gabapentin Shown Effective for Fibromyalgia Pain
5. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
6. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
7. XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer
8. Soliris Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
9. Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and Effective in Colorectal Cancer with Liver Metastases
10. Biotheras Imprime PGG Enhanced Effectiveness of Avastin in Cancer Study
11. Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Curecumin May Effective Treatment for Lung Cancer
(Date:3/31/2015)... HOUSTON , March 31, 2015 ... at the American Association of Orthodontics 2015 Annual ... leading orthodontists present scientific lectures on AcceleDent ® ... the leader in accelerated orthodontics, AcceleDent is a ... orthodontic treatment by as much as 50 percent ...
(Date:3/31/2015)... Pa. , March 31, 2015 ... against the board of directors of Hyperion Therapeutics, Inc. ... possible breaches of fiduciary duty and other violations of ... Company to Horizon Pharma plc in a transaction valued ... shares of Hyperion and would like to learn more ...
(Date:3/31/2015)... Ill. , March 31, 2015 ... ® Motion™-15-Days and Invia ® Motion™-Endure ... portfolio of products and services. These new devices, ... reflect Medela,s continued commitment to provide innovative, high-quality ... advanced wound treatment to patients. "We ...
Breaking Medicine Technology:Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3Ryan & Maniskas, LLP Announces Investigation of Hyperion Therapeutics, Inc. 2Medela Launches Product Line to Support Individualized Care For Negative Pressure Wound Therapy Patients 2
... Oct. 29 Stryker Corporation (NYSE: SYK ... a division of Porex Corporation. Porex Surgical is a ... (PPE) for use primarily in reconstructive surgery of the ... the PPE market with strong brand recognition and considerable ...
... LEIDEN, Netherlands, Oct. 29 Pursuant to the provisions of ... Takeover Bids (Besluit Openbare Biedingen Wft) requiring a public announcement ... offer to provide a status update, Johnson & Johnson (NYSE: ... CRXL ; Swiss Exchange: CRX) provide the following ...
Cached Medicine Technology:Stryker Announces Acquisition of Privately-Held Porex Surgical 2Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 2Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 3Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 4Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 5
(Date:3/31/2015)... Dr. St. Ledger recently returned from yet another trip ... Here, he participated in the Worn Dentition Workshop: a ... in cases of severely worn teeth, as well as the ... correlation to GERD and Sleep Apnea. , Dr. ... After the workshop he attended, he mentored for three days ...
(Date:3/31/2015)... March 31, 2015 Healthpointe’s team of ... at all of their clinics. Specialties include hip dislocations, ... , For athletes with hip injuries, Healthpointe has a ... and treat the symptoms and underlying causes of the ... care and prevent future damage, while taking into consideration ...
(Date:3/31/2015)... March 31, 2015 Beckman Coulter is sponsoring ... USP 787: “Subvisible Particulate Matter in Therapeutic Protein Injections”,” an ... new demands in counting particles in liquids, with a focus ... webinar is free to attend and will be broadcast live ... posted a new test for protein-based materials, known as ...
(Date:3/31/2015)... Fredericton, NB (PRWEB) March 31, 2015 Indosoft, ... than a decade, announce the availability of SIP over TCP ... their flagship software suite, offering a full contact center ... all over the world. Adding SIP over TCP support to ... to this system. , The history of Voice over IP ...
(Date:3/31/2015)... Greenfield Senior continues to build ... ("Care") a seniors housing-focused real estate investment and ... today, their acquisition of six senior housing communities ... Concurrent with the acquisition, Care will master lease ... ("Greenfield"). Pursuant to the lease, Care will provide ...
Breaking Medicine News(10 mins):Health News:The dentists at Upper Montclair Dental Associates are happy to announce exciting new happenings at their practice. 2Health News:Healthpointe Now Treating Hip Dislocations, Hip Fractures, Hip Bursitis, and Hip Strains at Locations in Southern California 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 3Health News:Indosoft extends SIP over TCP support to User Extensions in its Q-Suite 5.9 Call Center Software 2Health News:Greenfield Senior Living Inc. Enters Lease Transaction with Care Investment Trust LLC 2Health News:Greenfield Senior Living Inc. Enters Lease Transaction with Care Investment Trust LLC 3
... Center at Jefferson in Philadelphia have shown that by ... cells from metastatic dissemination. The work opens the door ... for therapies aimed at keeping prostate cancer at bay. ... laboratory and animal models, Marja Nevalainen, M.D., Ph.D., associate ...
... First- and Late-Line Treatment of NSCLC, CHICAGO, June ... from three clinical trials of XL647, a novel small ... Annual Meeting of the,American Society of Clinical Oncology (ASCO). ... untreated, clinically selected non-small cell,lung cancer (NSCLC) patients show ...
... Technologies Inc., a,leading developer and manufacturer of ... the company has entered into a,multi-million dollar ... multi- year exclusive agreement for cardiac Optical ... lasers for LightLab,s,next generation OCT imaging system., ...
... Funds to support product development and clinical ... 2 Cantimer, Inc., a privately,held company ... with applications in life science, biodefense, environmental,testing, ... announced,that it has been awarded a $996,000 ...
... DIEGO, June 2 Imagenetix, Inc. (OTC,Bulletin Board: ... a business,relationship with MonaVie LLC (http://www.monavie.com ) ... Active., Celadrin, a cellular lubricant, is a ... comfort. Providing continuous,lubrication, Celadrin improves cell membrane fluidity ...
... Treating pancreatic cancer with a combination of chemotherapy, ... may be beneficial for patients, according to a University ... 44th annual meeting of the American Society of Clinical ... physicians from the Pancreatic Cancer Center of the University ...
Cached Medicine News:Health News:Blocking signaling protein prevents prostate cancer spread, Jefferson scientists find 2Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 2Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 3Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 4Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 5Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 6Health News:Axsun Technologies Announces Exclusive Cardiac Supply Agreement for Advanced OCT Tunable Lasers with LightLab Imaging 2Health News:Cantimer, Inc. Awarded $996,000 Contract from U.S. Government to Develop Portable, Real-Time and Non-Invasive Hydration Measurement and Monitoring System for Use by Firefighters 2Health News:Imagenetix Enters into Business Relationship with MonaVie 2Health News:New treatment combination safe for pancreatic cancer patients 2
Phaco Chopper, double ended; a combination of a modified MicroFinger and a pointed "quick chop" tip, in titanium...
2.0mm Rounded Tip, 12mm From Tip to Bend Gently Curved, 15mm Shaft; In Titanium...
0.5X2.0mm Tip, Oval Shape; in Titanium....
Bend with "H" Shaped Tip, LEFT; in Titanium....
Medicine Products: